Carbamazepine Extended-Release for the Treatment of Bipolar Depression

NCT00203567 ↗

Phase 4 Completed 25 enrolled Tuscaloosa Research & Education Advancement Corporation Shire · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To study the efficacy and safety of beaded extended-release Carbamazepine (Equetro) in the treatment of patients with Bipolar Disorder with a Major Depressive Episode.

Timeline

Start: 2005-08
Primary completion: 2007-02
Completion: 2008-05

Publications

Background Swainston Harrison T, Keating GM. Extended-release carbamazepine capsules : in bipolar I disorder. CNS Drugs. 2005;19(8):709-16. doi: 10.2165/00023210-200519080-00006.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Carbamazepine	Small molecule	1200 mg	—

Carbamazepine Extended-Release for the Treatment of Bipolar Depression

Summary

Timeline

Publications

Drugs

Indications